DE69426077T2 - Adjuvantien für impfstoffe gegen das respiratorische synzitialvirus - Google Patents
Adjuvantien für impfstoffe gegen das respiratorische synzitialvirusInfo
- Publication number
- DE69426077T2 DE69426077T2 DE69426077T DE69426077T DE69426077T2 DE 69426077 T2 DE69426077 T2 DE 69426077T2 DE 69426077 T DE69426077 T DE 69426077T DE 69426077 T DE69426077 T DE 69426077T DE 69426077 T2 DE69426077 T2 DE 69426077T2
- Authority
- DE
- Germany
- Prior art keywords
- pct
- adjuvanties
- vaccine against
- sec
- respiratory syncitial
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US6785593A | 1993-05-25 | 1993-05-25 | |
US67855 | 1993-05-25 | ||
PCT/US1994/005833 WO1994027636A1 (en) | 1993-05-25 | 1994-05-24 | Adjuvants for vaccines against respiratory syncytial virus |
Publications (3)
Publication Number | Publication Date |
---|---|
DE69426077D1 DE69426077D1 (de) | 2000-11-09 |
DE69426077T2 true DE69426077T2 (de) | 2001-05-10 |
DE69426077T3 DE69426077T3 (de) | 2004-09-02 |
Family
ID=22078872
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69426077T Expired - Fee Related DE69426077T3 (de) | 1993-05-25 | 1994-05-24 | Adjuvantien für impfstoffe gegen das respiratorische synzitialvirus |
Country Status (15)
Country | Link |
---|---|
US (1) | US5723130A (de) |
EP (1) | EP0705109B2 (de) |
JP (1) | JP3734263B2 (de) |
AT (1) | ATE196737T1 (de) |
AU (1) | AU676340B2 (de) |
CA (1) | CA2163550A1 (de) |
DE (1) | DE69426077T3 (de) |
DK (1) | DK0705109T4 (de) |
ES (1) | ES2150493T5 (de) |
FI (1) | FI955667A (de) |
GR (1) | GR3034785T3 (de) |
NO (1) | NO954786L (de) |
PT (1) | PT705109E (de) |
RU (1) | RU2160119C2 (de) |
WO (1) | WO1994027636A1 (de) |
Families Citing this family (84)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9105992D0 (en) * | 1991-03-21 | 1991-05-08 | Smithkline Beecham Biolog | Vaccine |
GB9326253D0 (en) | 1993-12-23 | 1994-02-23 | Smithkline Beecham Biolog | Vaccines |
US6727230B1 (en) * | 1994-03-25 | 2004-04-27 | Coley Pharmaceutical Group, Inc. | Immune stimulation by phosphorothioate oligonucleotide analogs |
ATE322289T1 (de) * | 1994-10-05 | 2006-04-15 | Univ Vanderbilt | Interleukin-12 als adjuvans für paramyoxviridae impfstoffe |
US6488934B1 (en) * | 1995-02-25 | 2002-12-03 | Smithkline Beecham Biologicals S.A. | Hepatitis B vaccine |
UA56132C2 (uk) * | 1995-04-25 | 2003-05-15 | Смітклайн Бічем Байолоджікалс С.А. | Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини |
US6975708B1 (en) * | 1996-04-17 | 2005-12-13 | Convergys Cmg Utah, Inc. | Call processing system with call screening |
US5867562A (en) * | 1996-04-17 | 1999-02-02 | Scherer; Gordon F. | Call processing system with call screening |
US20020136739A1 (en) * | 1996-07-12 | 2002-09-26 | Cates George A. | Subunit respiratory syncytial virus preparation |
DE69720024D1 (de) * | 1996-07-12 | 2003-04-24 | Aventis Pasteur | Immunisierungsverfahren in zwei schritten gegen pyramyxoviridae-viren unter verwendung abgeschwächter viraler stämme und preparation von proteinuntereinheiten |
US6180398B1 (en) * | 1996-07-12 | 2001-01-30 | Virogeneitics Corporation | Two-step immunization procedure against the pyramyxoviridae family of viruses using recombinant virus and subunit protein preparation |
US6020182A (en) * | 1996-07-12 | 2000-02-01 | Connaught Laboratories Limited | Subunit respiratory syncytial virus vaccine preparation |
US6406705B1 (en) * | 1997-03-10 | 2002-06-18 | University Of Iowa Research Foundation | Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant |
GB9706957D0 (en) | 1997-04-05 | 1997-05-21 | Smithkline Beecham Plc | Formulation |
US6699478B1 (en) * | 1997-09-19 | 2004-03-02 | Wyeth Holdings Corporation | Enhanced immune response to attachment (G) protein of Respiratory Syncytial Virus |
TWI239847B (en) * | 1997-12-02 | 2005-09-21 | Elan Pharm Inc | N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease |
US20080050367A1 (en) * | 1998-04-07 | 2008-02-28 | Guriq Basi | Humanized antibodies that recognize beta amyloid peptide |
US6787523B1 (en) * | 1997-12-02 | 2004-09-07 | Neuralab Limited | Prevention and treatment of amyloidogenic disease |
US7790856B2 (en) * | 1998-04-07 | 2010-09-07 | Janssen Alzheimer Immunotherapy | Humanized antibodies that recognize beta amyloid peptide |
US7964192B1 (en) | 1997-12-02 | 2011-06-21 | Janssen Alzheimer Immunotherapy | Prevention and treatment of amyloidgenic disease |
US20050059802A1 (en) * | 1998-04-07 | 2005-03-17 | Neuralab Ltd | Prevention and treatment of amyloidogenic disease |
ES2296390T3 (es) * | 1998-05-07 | 2008-04-16 | Corixa Corporation | Composicion coadyuvante y procedimiento para su uso. |
GB9820525D0 (en) | 1998-09-21 | 1998-11-11 | Allergy Therapeutics Ltd | Formulation |
AU750587B2 (en) * | 1998-10-16 | 2002-07-25 | Smithkline Beecham Biologicals (Sa) | Adjuvant systems and vaccines |
US7198920B1 (en) * | 1999-01-29 | 2007-04-03 | Corika Corporation | HER-2/neu fusion proteins |
GB9909077D0 (en) * | 1999-04-20 | 1999-06-16 | Smithkline Beecham Biolog | Novel compositions |
CA2365411A1 (en) * | 1999-03-26 | 2000-10-05 | Walter Reed Army Institute Of Research | Attenuated dengue-2 virus vaccine |
EP1165127B1 (de) * | 1999-03-26 | 2008-12-31 | Walter Reed Army Institute of Research | Multivalenter dengue-virus impfstoff |
JP2002540171A (ja) * | 1999-03-26 | 2002-11-26 | ウォルター リード アーミー インスティテュート オブ リサーチ | 弱毒化デング熱4型ウイルスワクチン |
TR200103266T2 (tr) * | 1999-05-13 | 2002-01-21 | American Cyanamid Company | Yardımcı kombinasyon formülasyonları |
GB0000891D0 (en) | 2000-01-14 | 2000-03-08 | Allergy Therapeutics Ltd | Formulation |
WO2001097841A2 (en) * | 2000-06-22 | 2001-12-27 | American Cyanamid Company | Qs-21 and il-12 as an adjuvant combination |
US7229623B1 (en) * | 2000-08-03 | 2007-06-12 | Corixa Corporation | Her-2/neu fusion proteins |
EA004744B1 (ru) * | 2000-11-10 | 2004-08-26 | Уайт Холдингз Корпорейшн | Комбинированные композиции адъювантов |
US7700751B2 (en) | 2000-12-06 | 2010-04-20 | Janssen Alzheimer Immunotherapy | Humanized antibodies that recognize β-amyloid peptide |
DE10205373B4 (de) * | 2002-02-09 | 2007-07-19 | Aloys Wobben | Brandschutz |
MY139983A (en) * | 2002-03-12 | 2009-11-30 | Janssen Alzheimer Immunotherap | Humanized antibodies that recognize beta amyloid peptide |
BRPI0407058A (pt) * | 2003-02-01 | 2006-01-17 | Neuralab Ltd | Métodos de profilaxia e de tratamento de uma doença, composição farmacêutica, e, uso de um fragmento |
US20060095001A1 (en) * | 2004-10-29 | 2006-05-04 | Transcutaneous Technologies Inc. | Electrode and iontophoresis device |
US8916165B2 (en) * | 2004-12-15 | 2014-12-23 | Janssen Alzheimer Immunotherapy | Humanized Aβ antibodies for use in improving cognition |
JP2006346368A (ja) * | 2005-06-20 | 2006-12-28 | Transcutaneous Technologies Inc | イオントフォレーシス装置及びその製造方法 |
JP2007000342A (ja) * | 2005-06-23 | 2007-01-11 | Transcutaneous Technologies Inc | 複数薬剤の投与量および投与時期を制御するイオントフォレーシス装置 |
US8295922B2 (en) | 2005-08-08 | 2012-10-23 | Tti Ellebeau, Inc. | Iontophoresis device |
US8386030B2 (en) * | 2005-08-08 | 2013-02-26 | Tti Ellebeau, Inc. | Iontophoresis device |
US20070088332A1 (en) * | 2005-08-22 | 2007-04-19 | Transcutaneous Technologies Inc. | Iontophoresis device |
US20090254018A1 (en) * | 2005-08-24 | 2009-10-08 | Mizuo Nakayama | Electrode assembly for freezing-type iontophoresis device |
US20070048362A1 (en) * | 2005-08-29 | 2007-03-01 | Transcutaneous Technologies Inc. | General purpose electrolyte solution composition for iontophoresis |
JPWO2007029611A1 (ja) * | 2005-09-06 | 2009-03-19 | Tti・エルビュー株式会社 | イオントフォレーシス装置 |
US20070112294A1 (en) * | 2005-09-14 | 2007-05-17 | Transcutaneous Technologies Inc. | Iontophoresis device |
JPWO2007032446A1 (ja) * | 2005-09-15 | 2009-03-19 | Tti・エルビュー株式会社 | ロッド型イオントフォレーシス装置 |
CN101262905A (zh) * | 2005-09-16 | 2008-09-10 | Tti优而美株式会社 | 探针式离子电渗疗装置 |
WO2007037324A1 (ja) * | 2005-09-28 | 2007-04-05 | Transcu Ltd. | 乾燥型イオントフォレーシス用電極構造体 |
JP2009509634A (ja) * | 2005-09-30 | 2009-03-12 | Tti・エルビュー株式会社 | 官能基化マイクロニードル経皮薬剤送達システム、装置及び方法 |
WO2007037476A1 (ja) * | 2005-09-30 | 2007-04-05 | Tti Ellebeau, Inc. | 睡眠導入剤と興奮剤の投与量および投与時期を制御するイオントフォレーシス装置 |
WO2007037475A1 (ja) * | 2005-09-30 | 2007-04-05 | Tti Ellebeau, Inc. | 形状記憶セパレータを有するイオントフォレーシス用電極構造体およびそれを用いたイオントフォレーシス装置 |
KR20080066712A (ko) * | 2005-09-30 | 2008-07-16 | 티티아이 엘뷰 가부시키가이샤 | 관능화된 미세바늘 경피 약물 전달 시스템, 장치 및 방법 |
EP1931417A2 (de) * | 2005-09-30 | 2008-06-18 | Transcutaneous Technologies Inc. | Transdermale arzneiabgabesysteme, vorrichtungen und verfahren mit neuen pharmazeutischen vehikeln |
EP1928542A1 (de) * | 2005-09-30 | 2008-06-11 | Tti Ellebeau, Inc. | Verfahren und system zum nachweis von fehlfunktionen in einer iontophorese-vorrichtung, die wirkstoffe an biologische schnittstellen abgibt |
CN101277737A (zh) * | 2005-09-30 | 2008-10-01 | Tti优而美株式会社 | 将多种活性剂输送至生物界面的离子电渗装置 |
JP2009509677A (ja) * | 2005-09-30 | 2009-03-12 | Tti・エルビュー株式会社 | 小胞封入活性物質のイオントフォレーシス送達 |
US20070135754A1 (en) * | 2005-09-30 | 2007-06-14 | Hidero Akiyama | Electrode assembly for iontophoresis for administering active agent enclosed in nanoparticle and iontophoresis device using the same |
US20070197955A1 (en) * | 2005-10-12 | 2007-08-23 | Transcutaneous Technologies Inc. | Mucous membrane adhesion-type iontophoresis device |
US20080033338A1 (en) * | 2005-12-28 | 2008-02-07 | Smith Gregory A | Electroosmotic pump apparatus and method to deliver active agents to biological interfaces |
US20080033398A1 (en) * | 2005-12-29 | 2008-02-07 | Transcutaneous Technologies Inc. | Device and method for enhancing immune response by electrical stimulation |
US8784810B2 (en) * | 2006-04-18 | 2014-07-22 | Janssen Alzheimer Immunotherapy | Treatment of amyloidogenic diseases |
WO2009017467A1 (en) * | 2007-07-27 | 2009-02-05 | Elan Pharma International Limited | Treatment of amyloidogenic diseases |
JP2010502293A (ja) * | 2006-09-05 | 2010-01-28 | Tti・エルビュー株式会社 | 誘導型電源を用いる経皮薬物送達システム、装置及び方法 |
JP5383497B2 (ja) | 2006-12-01 | 2014-01-08 | Tti・エルビュー株式会社 | 装置、例として経皮送達装置に給電し且つ/又は当該装置を制御するシステム及び装置 |
AU2008242648B2 (en) * | 2007-04-18 | 2013-09-12 | Janssen Alzheimer Immunotherapy | Prevention and treatment of cerebral amyloid angiopathy |
US8003097B2 (en) * | 2007-04-18 | 2011-08-23 | Janssen Alzheimer Immunotherapy | Treatment of cerebral amyloid angiopathy |
EP1997830A1 (de) | 2007-06-01 | 2008-12-03 | AIMM Therapeutics B.V. | RSV-spezifische Bindemoleküle und Mittel zu ihrer Herstellung |
JO3076B1 (ar) * | 2007-10-17 | 2017-03-15 | Janssen Alzheimer Immunotherap | نظم العلاج المناعي المعتمد على حالة apoe |
US7736648B2 (en) * | 2007-10-25 | 2010-06-15 | Trellis Bioscience, Inc. | Anti-RSV G protein antibodies |
US9067981B1 (en) | 2008-10-30 | 2015-06-30 | Janssen Sciences Ireland Uc | Hybrid amyloid-beta antibodies |
US20100312168A1 (en) * | 2009-06-09 | 2010-12-09 | Yoshimasa Yoshida | Long life high capacity electrode, device, and method of manufacture |
US8883717B2 (en) | 2012-03-30 | 2014-11-11 | Artificial Cell Technologies, Inc. | Antigenic compositions and methods |
US9433671B2 (en) | 2012-03-30 | 2016-09-06 | Artificial Cell Technologies, Inc. | Anti-malaria compositions and methods |
CA2981359C (en) * | 2015-04-16 | 2023-06-27 | The Research Foundation For The State University Of New York | Nanostructures comprising cobalt porphyrin-phospholipid conjugates and polyhistidine-tags |
EP3349788A4 (de) | 2015-09-16 | 2019-06-05 | Artificial Cell Technologies, Inc. | Antimalariazusammensetzungen und verfahren |
US11043823B2 (en) * | 2017-04-06 | 2021-06-22 | Tesla, Inc. | System and method for facilitating conditioning and testing of rechargeable battery cells |
JP2021533157A (ja) * | 2018-08-07 | 2021-12-02 | ウィスコンシン アルムニ リサーチ ファンデイション | 組換えの生物学的に封じ込められたフィロウイルスワクチン |
CN113874496A (zh) | 2019-02-08 | 2021-12-31 | 威斯康星校友研究基金会(Warf) | 人源化细胞系 |
WO2021041624A2 (en) | 2019-08-27 | 2021-03-04 | Yoshihiro Kawaoka | Recombinant influenza viruses with stabilized ha for replication in eggs |
CA3208643A1 (en) | 2021-01-18 | 2022-07-21 | Conserv Bioscience Limited | Coronavirus immunogenic compositions, methods and uses thereof |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1188985A (en) † | 1980-07-01 | 1985-06-18 | Edward J. Stott | Production of viral antigens |
US5057540A (en) * | 1987-05-29 | 1991-10-15 | Cambridge Biotech Corporation | Saponin adjuvant |
JP2716503B2 (ja) * | 1987-12-23 | 1998-02-18 | ジ・アップジョン・カンパニー | ヒト呼吸系シンシチウムウイルスの糖蛋白類の免疫原性セグメントを含有するキメラ糖蛋白類 |
GB9105992D0 (en) * | 1991-03-21 | 1991-05-08 | Smithkline Beecham Biolog | Vaccine |
GB9120221D0 (en) † | 1991-09-23 | 1991-11-06 | Smithkline Beecham Biolog | Novel compounds |
EP0812593B8 (de) * | 1993-03-23 | 2010-11-10 | SmithKline Beecham Biologicals S.A. | 3-0-Deazylierte Monophosphoryl Lipid A enthaltende Impfstoff-Zusammensetzungen |
-
1994
- 1994-05-24 US US08/553,332 patent/US5723130A/en not_active Expired - Fee Related
- 1994-05-24 RU RU95122391/14A patent/RU2160119C2/ru not_active IP Right Cessation
- 1994-05-24 PT PT94918109T patent/PT705109E/pt unknown
- 1994-05-24 EP EP94918109A patent/EP0705109B2/de not_active Expired - Lifetime
- 1994-05-24 CA CA002163550A patent/CA2163550A1/en not_active Abandoned
- 1994-05-24 DK DK94918109T patent/DK0705109T4/da active
- 1994-05-24 WO PCT/US1994/005833 patent/WO1994027636A1/en active IP Right Grant
- 1994-05-24 JP JP50089995A patent/JP3734263B2/ja not_active Expired - Fee Related
- 1994-05-24 DE DE69426077T patent/DE69426077T3/de not_active Expired - Fee Related
- 1994-05-24 AU AU69571/94A patent/AU676340B2/en not_active Ceased
- 1994-05-24 ES ES94918109T patent/ES2150493T5/es not_active Expired - Lifetime
- 1994-05-24 AT AT94918109T patent/ATE196737T1/de not_active IP Right Cessation
-
1995
- 1995-11-24 FI FI955667A patent/FI955667A/fi unknown
- 1995-11-24 NO NO954786A patent/NO954786L/no not_active Application Discontinuation
-
2000
- 2000-11-08 GR GR20000402474T patent/GR3034785T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
EP0705109B1 (de) | 2000-10-04 |
AU6957194A (en) | 1994-12-20 |
DK0705109T3 (da) | 2000-11-13 |
ES2150493T5 (es) | 2004-07-01 |
ATE196737T1 (de) | 2000-10-15 |
EP0705109A1 (de) | 1996-04-10 |
PT705109E (pt) | 2001-02-28 |
AU676340B2 (en) | 1997-03-06 |
DE69426077T3 (de) | 2004-09-02 |
FI955667A0 (fi) | 1995-11-24 |
NO954786L (no) | 1996-01-23 |
DE69426077D1 (de) | 2000-11-09 |
EP0705109A4 (de) | 1998-09-02 |
US5723130A (en) | 1998-03-03 |
ES2150493T3 (es) | 2000-12-01 |
JP3734263B2 (ja) | 2006-01-11 |
FI955667A (fi) | 1996-01-12 |
RU2160119C2 (ru) | 2000-12-10 |
GR3034785T3 (en) | 2001-02-28 |
CA2163550A1 (en) | 1994-12-08 |
NO954786D0 (no) | 1995-11-24 |
DK0705109T4 (da) | 2004-05-10 |
JPH08510749A (ja) | 1996-11-12 |
EP0705109B2 (de) | 2004-01-02 |
WO1994027636A1 (en) | 1994-12-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69426077D1 (de) | Adjuvantien für impfstoffe gegen das respiratorische synzitialvirus | |
CA2181832A1 (en) | Immunization by inoculation of dna transcription unit | |
GB2322801B (en) | Vaccine compositions for intranasal administration comprising chitosan and use thereof | |
RU95122391A (ru) | Адъюванты для вакцины против распираторно-синцитиального вируса | |
DE69332643D1 (de) | Menschliche, neutralisierende, monoklonale antikörper gegen das respiratorische synzytialvirus | |
DE69840383D1 (de) | Ctl epitope des epstein-barr virus | |
FI944676A0 (fi) | Rokotteita, jotka sisältävät ionisoitumattomia pinta-aktiivisten aineiden vesikkeleitä | |
DK0745387T3 (da) | Adjuvanser til virale vacciner | |
EP2796148A3 (de) | Kombinierte Meningitis B/C-Impfstoffe | |
PT1409692E (pt) | Novos péptidos do derivados da proteína g do vírus respiratório sincicial (vrs) e sua utilização numa vacina | |
BR9814204A (pt) | "obtenção de vacinas destinadas a prevenir os efeitos patogênicos associados a uma infecção retroviral" | |
AU5457496A (en) | Adjuvants for viral vaccines | |
AU2238597A (en) | Iscom or iscom-matrix comprising a mucus targetting substance and optionally, an antigen | |
WO1998040097A3 (en) | Bovine respiratory and enteric coronavirus as a vaccine | |
OA09037A (en) | Prevention and treatement of retroviral disease. | |
BR9909076A (pt) | Vìrus atenuado do sarampo, recombinantemente gerado, isolado, vìrus do sarampo, vìrus sincicial respiratório humano (rsv), subgrupo b, atenuado, recombinantemente gerado, isolado, o rsv, subgrupo b, vacina processo para imunização de um indivìduo para induzir proteção contra vìrus do sarampo, processo para imunização de um indivìduo para induzir proteção contra o rsv, subgrupo b, composição, processo para produção de vìrus do sarampo infeccioso atenuado, processo para produção de rsv infeccioso atenuado subgrupo b | |
NO20011075D0 (no) | Peptidfragmenter av kolera-toksin eller enterotoksin som vaksineadjuvanser | |
GB9018061D0 (en) | Compositions for vaccines | |
FR2698271B1 (fr) | Vaccin contre le virus de la leucémie bovine, nouveau peptide immunogène et kit de vaccination. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8363 | Opposition against the patent | ||
8366 | Restricted maintained after opposition proceedings | ||
8327 | Change in the person/name/address of the patent owner |
Owner name: WYETH HOLDINGS CORP., MADISON, N.J., US |
|
8339 | Ceased/non-payment of the annual fee |